PDS Biotechnology Corp — Director's Dealing 2020

Feb 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2020-02-14

Reporting Person: Glover Steve C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-14	Common Stock	A	38400	$1.3	Acquired	57908	Direct

Footnotes

F1: Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on February 14, 2020.

F2: Represents 19,508 shares of common stock previously issued to the Reporting Person. The Reporting Person was a former stockholder of privately held PDS Biotechnology Corporation, a Delaware corporation ("Private PDS"). The Reporting Person received such shares of Issuer in exchange for the shares of common stock the Reporting Person formerly held in Private PDS in connection with the previously disclosed business combination with Private PDS, which was consummated on March 15, 2019.